JUPITER, Fla., Oct. 16, 2026 /PRNewswire/ — Myosin Therapeutics today announced that, following its selection as a 2026–2027 National Cancer Institute (NCI) SBIR Investor Initiatives Showcase Company, it has been invited to present at BioFuture 2026, taking place October 27–28 in New…
Source: Read More